The relationship between deiodinase activity and inflammatory responses under the stimulation of uremic toxins

Gaosi Xu1, Weiping Tu, Shulan Qin

  • 1Nanchang University, Nanchang, China. gaosixu@163.com.

Abstract

Insights

Uremic toxins promote inflammation and inhibit deiodinase type 1 (DIO1) activity. This inhibition creates a feedback loop, increasing inflammatory cytokines in conditions like liver cancer.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hepatology

Background:

  • Uremic toxins are implicated in inflammation, but their precise role alongside deiodinases and inflammatory cytokines remains unclear.
  • The interplay between deiodinases, such as deiodinase type 1 (DIO1), and inflammatory processes requires further elucidation.

Purpose of the Study:

  • To investigate the impact of uremic toxins on deiodinase type 1 (DIO1) expression and activity.
  • To examine the relationship between uremic toxins, DIO1, and the expression of key inflammatory cytokines (IL-1β, IL-6, TNF-α).

Main Methods:

  • Hepatocellular carcinoma (HepG2) cells were treated with siRNA targeting DIO1 and exposed to uremic toxins.
  • Quantitative real-time PCR and western blotting were used to measure mRNA and protein expression of DIO1, selenoprotein M (SelM), and inflammatory cytokines.
  • Enzyme activity assays and electrophoretic mobility shift assays (EMSA) assessed DIO1 activity and inflammatory signaling pathways (NF-κB, AP-1, CREB-1).

Main Results:

  • siRNA significantly reduced DIO1 mRNA expression by 76%.
  • Uremic toxins increased IL-1β, IL-6, and TNF-α mRNA expression while decreasing DIO1 mRNA expression.
  • DIO1 suppression by siRNA reduced IL-1β and IL-6 mRNA but not TNF-α. Both uremic toxins and siRNA decreased SelM and DIO1 protein levels.

Conclusions:

  • Uremic toxins directly inhibit DIO1 enzyme activity, contributing to the accumulation of inflammatory cytokines.
  • This study reveals a negative feedback mechanism where uremic toxins exacerbate inflammation by suppressing DIO1, impacting liver cancer cell lines.

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
23
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
12.4K
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
519
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
22
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
365